Clinical trial

Immune System Function Following Vaccination in HIV Infected Children Taking…

NCT00257127 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed

Key facts

NCT number NCT00257127
Title Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs
Official title Evaluation of Immunologic Memory Following Pneumococcal, Hepatitis B, and Measles Vaccination in HIV Infected Children Treated With Highly Active Antiretroviral Therapy (HAART)
Lead sponsor National Institute of Allergy and Infectious Diseases (NIAID), NIH
Collaborators Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH
Status Completed
Study type Interventional
Conditions HIV Infections
Intervention type Biological
Interventions Pneumococcal 7-valent conjugate vaccine, Pneumococcal polysaccharide vaccine, Hepatitis B vaccine, Measles, mumps, and rubella virus vaccine, live
Enrollment 101
Start date Feb 1, 2006
Primary completion Aug 1, 2006
Completion Aug 1, 2006
First posted Nov 22, 2005
Last update posted Nov 1, 2021
Countries Puerto Rico, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies